Epilepsy, Tonic-Clonic
13
1
1
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.7%
1 terminated out of 13 trials
90.0%
+3.5% vs benchmark
54%
7 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (13)
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
EpiWatch: Evaluation of a Non-EEG Physiological Signal Based Seizure Monitoring System
Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
Embrace and Quality of Life
XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)
Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.
Topiramate Bioequivalence Study Brazil - Fast
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures
Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.
A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy